Monoclonal Antibody and Antiviral Therapy for Mild-to-Moderate COVID-19 in Pediatric Patients

被引：10

作者：

Vora, Surabhi B. B. ^{[1
,4
]}

Englund, Janet A. A. ^{[1
]}

Trehan, Indi ^{[1
]}

Waghmare, Alpana ^{[1
]}

Kong, Ada ^{[2
]}

Adler, Amanda ^{[3
]}

Zerr, Danielle M. M. ^{[1
]}

机构：

[1] Univ Washington, Dept Pediat, Seattle, WA USA

[2] Seattle Childrens Hosp, Dept Pharm, Seattle, WA 98105 USA

[3] Seattle Childrens Hosp, Div Infect Dis, Seattle, WA 98105 USA

[4] Seattle Childrens Hosp, 4800 Sand Point Way NE, Seattle, WA 98105 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2023年 / 42卷 / 01期

关键词：

SARS-CoV-2; pediatrics; monoclonal antibodies; antivirals; STATES;

D O I：

10.1097/INF.0000000000003740

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Multiple antiviral and monoclonal antibody therapies are now available for mild-moderate COVID-19 in high-risk patients >= 12 years of age. However, data for the use of these agents in children is limited. We reviewed 94 pediatric patients for whom early therapy was requested since the emergence of the Omicron variant and describe patient characteristics, treatment logistics and associated short-term events.

引用

页码：32 / 34

页数：3

共 50 条

[1] Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience
Amanam, Idoroenyi
Yao, Janny
Puing, Alfredo
Tsai, Ni-Chun
Samuels, Diana
Ngo, Dat
Ho, Stephanie
Ali, Haris
Aribi, Ahmed
Arslan, Shukaib
Artz, Andrew
Htut, Myo
Koller, Paul
Salhotra, Amandeep
Sandhu, Karamjeet
Nikolaenko, Liana
Pawlowska, Anna
Shouse, Geoffrey
Stein, Anthony
Marcucci, Guido
Forman, Stephen
Nakamura, Ryotaro
Dadwal, Sanjeet
Al Malki, Monzr M. M.
[J]. CANCER MEDICINE, 2023, 12 (10): : 11248 - 11253
[2] Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19
Malani, Preeti N.
Golub, Robert M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 644 - 645
[3] Emergency Department-Based Monoclonal Antibody Therapy for Patients With Mild to Moderate COVID-19
Lim, C.
Eiting, E.
O'Neill, A.
Farraj, R.
Koshy, S.
Simms, C.
Devlin, A.
Nunez, J.
Calderon, Y.
[J]. ANNALS OF EMERGENCY MEDICINE, 2021, 78 (02) : S15 - S15
[4] Azithromycin for mild-to-moderate COVID-19
Patel, Jigar
Berezowski, Ivan
Abdelmonem, Ahmed
Taylor, Dania
Pourmand, Ali
[J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : E99 - E99
[5] Features of Mild-to-Moderate COVID-19 Patients With Dysphonia
Lechien, Jerome R.
Chiesa-Estomba, Carlos M.
Cabaraux, Pierre
Mat, Quentin
Huet, Kathy
Harmegnies, Bernard
Horoi, Mihaela
Le Bon, Serge Daniel
Rodriguez, Alexandra
Dequanter, Didier
Hans, Stephane
Crevier-Buchman, Lise
Hochet, Baptiste
Distinguin, Lea
Chekkoury-Idrissi, Younes
Circiu, Marta
El Afia, Fahd
Barillari, Maria Rosaria
Cammaroto, Giovanni
Fakhry, Nicolas
Michel, Justin
Radulesco, Thomas
Martiny, Delphine
Lavigne, Philippe
Jouffe, Lionel
Descamps, Geraldine
Journe, Fabrice
Trecca, Eleonora M. C.
Hsieh, Julien
Delgado, Irene Lopez
Calvo-Henriquez, Christian
Vergez, Sebastien
Khalife, Mohamad
Molteni, Gabriele
Mannelli, Giuditta
Cantarella, Giovanna
Tucciarone, Manuel
Souchay, Christel
Leich, Pierre
Ayad, Tareck
Saussez, Sven
[J]. JOURNAL OF VOICE, 2022, 36 (02) : 249 - 255
[6] Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
Thilagar, Bright P.
Ghosh, Aditya K.
Nguyen, Jerome
Theiler, Regan N.
Wick, Myra J.
Hurt, Ryan T.
Razonable, Raymund R.
Ganesh, Ravindra
[J]. OBSTETRICS AND GYNECOLOGY, 2022, 139 (04): : 616 - 618
[7] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
Moser, Carlee B.
Li, Jonathan Z.
Hughes, Michael D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (16): : 1533 - 1535
[8] Mild-to-Moderate Croup Presentations in Patients With COVID-19 Infection
Mathew, Danica
Calderon, Jose Cucalon
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
[9] Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19
Cao, Bin
Wang, Yeming
Lu, Hongzhou
Huang, Chaolin
Yang, Yumei
Shang, Lianhan
Chen, Zhu
Jiang, Rongmeng
Liu, Yihe
Lin, Ling
Peng, Ping
Wang, Fuxiang
Gong, Fengyun
Hu, Honglin
Cheng, Cong
Yao, Xiangyang
Ye, Xianwei
Zhou, Hourong
Shen, Yinzhong
Liu, Chenfan
Wang, Chunying
Yi, Zhennan
Hu, Bijie
Xu, Jiuyang
Gu, Xiaoying
Shen, Jingshan
Xu, Yechun
Zhang, Leike
Fan, Jia
Tang, Renhong
Wang, Chen
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (03): : 230 - 241
[10] The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19
Arimura, Ken
Tagaya, Etsuko
Kikuchi, Ken
Mitsuda, Toshihiro
Ebihara, Fumiya
Maruyama, Takumi
Hamada, Yukihiro
Unagami, Kohei
Kanzawa, Taichi
Sekiguchi, Haruki
Shimamoto, Ken
Ishida, Hideki
Egawa, Hiroto
Tanaka, Junji
Kawana, Masatoshi
[J]. TRANSPLANT IMMUNOLOGY, 2023, 77

← 1 2 3 4 5 →